Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial record for pembrolizumab combined with radiation therapy in non-small cell lung cancer is now displayed instead of an error page. It includes study design and eligibility details, outcome measures, publications, and study documents.SummaryDifference100%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA general NIH announcement about terminology changes appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error instead of the study details, displaying a minimal header and a 403 message. This reflects an access issue rather than changes to the study information.SummaryDifference26%

- Check59 days agoChange DetectedThe page shows a new revision version, from v3.6.6 to v3.7.0, indicating an updated build of the site. Content and public study details remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.